Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/37592
Title: Prognostic implications of left ventricular diastolic dysfunction in moderate aortic stenosis
Authors: STASSEN, Jan 
Ewe, See Hooi
Butcher, Steele C.
Amanullah, Mohammed R.
Mertens, Bart J.
Hirasawa, Kensuke
Singh, Gurpreet K.
Sin, Kenny Y.
Ding, Zee Pin
Pio, Stephan M.
Sia, Ching-Hui
Chew, Nicholas
Kong, William
Poh, Kian Keong
Cohen, David
Genereux, Philippe
Leon, Martin B.
Marsan, Nina Ajmone
Delgado, Victoria
Bax, Jeroen J.
Issue Date: 2022
Publisher: BMJ PUBLISHING GROUP
Source: HEART, 108 (17), p. 1401-1407
Abstract: Objective To investigate the prognostic impact of left ventricular (LV) diastolic dysfunction in patients with moderate aortic stenosis (AS) and preserved LV systolic function. Methods Patients with a first diagnosis of moderate AS (aortic valve area >1.0 and <= 1.5 cm(2)) and preserved LV systolic function (LV ejection fraction >= 50%) were identified. LV diastolic function was evaluated using echocardiographic criteria according to the 2016 American Society of Echocardiography/European Association of Cardiovascular Imaging guidelines. Clinical outcomes were defined as all-cause mortality and a composite of all-cause mortality and aortic valve replacement (AVR). Results Of 1247 patients (age 74 +/- 10 years, 47% men), 535 (43%) had LV diastolic dysfunction at baseline. Patients with LV diastolic dysfunction showed significantly higher mortality rates at 1-year, 3-year and 5-year follow-up (13%, 30% and 41%, respectively) when compared with patients with normal LV diastolic function (6%, 17% and 29%, respectively) (p<0.001). On multivariable analysis, LV diastolic dysfunction was independently associated with all-cause mortality (HR 1.368; 95% CI 1.085 to 1.725; p=0.008) and the composite endpoint of all-cause mortality and AVR (HR 1.241; 95% CI 1.035 to 1.488; p=0.020). Conclusions LV diastolic dysfunction is independently associated with all-cause mortality and the composite endpoint of all-cause mortality and AVR in patients with moderate AS and preserved LV systolic function. Assessment of LV diastolic function therefore contributes significantly to the risk stratification of patients with moderate AS. Future clinical trials are needed to investigate whether patients with moderate AS and LV diastolic dysfunction may benefit from earlier valve intervention.
Notes: Bax, JJ (corresponding author), Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Zuid Holland, Netherlands.
j.j.bax@lumc.nl
Keywords: Echocardiography;Transcatheter Aortic Valve Replacement;Heart Valve Prosthesis Implantation;Aortic Valve Stenosis
Document URI: http://hdl.handle.net/1942/37592
ISSN: 1355-6037
e-ISSN: 1468-201X
DOI: 10.1136/heartjnl-2022-320886
ISI #: WOS:000810552600001
Rights: Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Category: A1
Type: Journal Contribution
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
1401.full.pdf
  Restricted Access
Published version1.05 MBAdobe PDFView/Open    Request a copy
Show full item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.